Bone Formation is Affected by Matrix Advanced Glycation End Products (AGEs) In Vivo. (Q51311945)

3 April 2018

title

Bone Formation is Affected by Matrix Advanced Glycation End Products (AGEs) In Vivo. (English)

1 reference

3 April 2018

author name string

Xiao Yang

1

1 reference

3 April 2018

Ahmed Jenan Mostafa

2

1 reference

3 April 2018

Mark Appleford

3

1 reference

3 April 2018

Lian-Wen Sun

4

1 reference

3 April 2018

Xiaodu Wang

5

1 reference

3 April 2018

language of work or name

English

0 references

publication date

30 May 2016

1 reference

3 April 2018

Calcified Tissue International

published in

1 reference

3 April 2018

volume

99

1 reference

3 April 2018

page(s)

373-383

1 reference

3 April 2018

issue

4

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00223-016-0153-3

exact match

0 references

cites work

Pentosidine effects on human osteoblasts in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Advanced glycation end products and bone loss during aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Role of advanced glycation end products (AGEs) in osteoporosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Effects of non-enzymatic glycation on cancellous bone fragility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Pentosidine and increased fracture risk in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

The AGE of the matrix: chemistry, consequence and cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Influence of nonenzymatic glycation on biomechanical properties of cortical bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Nanoindentation measurements of biomechanical properties in mature and newly formed bone tissue surrounding an implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Bone marrow composition and bone microarchitecture and turnover in blacks and whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

Impaired growth plate function in bmp-6 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

The degree of mineralization is a determinant of bone strength: a study on human calcanei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

The effects of elevated hemoglobin A(1c) in patients with type 2 diabetes mellitus on dental implants: Survival and stability at one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-016-0153-3

10.1007/S00223-016-0153-3

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

27240574

1 reference

3 April 2018